Pablo J. Muinos-Antunez

Journal: EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology

Published: August 19, 2024

Low-Dose Direct Oral Anticoagulation vs Dual Antiplatelet Therapy After Left Atrial Appendage Occlusion: The ADALA Randomized Clinical Trial.

Journal: JAMA cardiology

Published: August 07, 2024

Triple Versus Dual Lipid-Lowering Therapy in Acute Coronary Syndrome: The ES-BempedACS Randomized Clinical Trial.

Triple Versus Dual Lipid-Lowering Therapy in Acute Coronary Syndrome: The ES-BempedACS Randomized Clinical Trial.

Low-dose direct oral anticoagulation vs dual antiplatelet therapy after left atrial appendage occlusion: 1-year results from the ADALA trial.

Low-dose direct oral anticoagulation vs dual antiplatelet therapy after left atrial appendage occlusion: 1-year results from the ADALA trial.

Serological protection against influenza and cardiovascular events in cardiac ICU patients during seasonal epidemics.

Serological protection against influenza and cardiovascular events in cardiac ICU patients during seasonal epidemics.

Serological protection against influenza and cardiovascular events in cardiac ICU patients during seasonal epidemics.

Serological protection against influenza and cardiovascular events in cardiac ICU patients during seasonal epidemics.

Left Atrial Appendage Occlusion Compared to Anticoagulation in Patients Suffering from Atrial Fibrillation with Advanced Chronic Kidney Disease.

Left Atrial Appendage Occlusion Compared to Anticoagulation in Patients Suffering from Atrial Fibrillation with Advanced Chronic Kidney Disease.

Real-World Experience With a Suprannular Self-Expanding Transcatheter Aortic Valve: The ALLOW Study.

Real-World Experience With a Suprannular Self-Expanding Transcatheter Aortic Valve: The ALLOW Study.

Heterotopic Crosscaval Transcatheter Tricuspid Valve Replacement for Patients With Tricuspid Regurgitation: The Trillium Device.

Heterotopic Crosscaval Transcatheter Tricuspid Valve Replacement for Patients With Tricuspid Regurgitation: The Trillium Device.

Left atrial appendage occlusion in patients with atrial fibrillation and cancer. Short- and mid-term outcomes.

Left atrial appendage occlusion in patients with atrial fibrillation and cancer. Short- and mid-term outcomes.

A comparison of simplified or conventional antithrombotic regimens after left atrial appendage closure in patients at high bleeding risk: the PLATEBRISK study.

A comparison of simplified or conventional antithrombotic regimens after left atrial appendage closure in patients at high bleeding risk: the PLATEBRISK study.

Low-Dose Direct Oral Anticoagulation vs Dual Antiplatelet Therapy After Left Atrial Appendage Occlusion: The ADALA Randomized Clinical Trial.

Low-Dose Direct Oral Anticoagulation vs Dual Antiplatelet Therapy After Left Atrial Appendage Occlusion: The ADALA Randomized Clinical Trial.

[[Transcatheter mitral paravalvular leak closure with the KONAR occluder device]].

[[Transcatheter mitral paravalvular leak closure with the KONAR occluder device]].

Role of computed tomography in transcatheter coronary and structural heart disease interventions.

Role of computed tomography in transcatheter coronary and structural heart disease interventions.